rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Agape ATP Corporation

ATPC · Nasdaq

Health CareProviders & FacilitiesNot moving yet

ATPC stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 40.0% below that average now. Providers & Facilities: 45% of its 53 stocks in an uptrend (−6 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 52
Industry in uptrend
45% -6 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
2 (+0)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

17 Apr – 16 Oct
26%43%59%Apr 26Jun 26Jul 26Sep 26Oct 26

Providers & Facilities: About half its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders2+0 on the quarter
New · exited0 · 0
Reported value$136K

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
JANE STREET GROUP, LLCadded · filed 14 Aug 202645,934$136K+22,274+94.1%
UBS Group AGreduced · filed 13 Aug 20268$24-2,582−99.7%
30 Sep 2024 – 30 Jun 2026
246Sep 24Mar 25Sep 25Dec 25Jun 26

News

No headline names it lately.

Everyone who traded it

Nobody on record has traded it.

Same industry

PACS PACS GroupLeading+18%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202555.0%
Operating profit marginFY 2025 · to 31 Dec 2025-214%
Return on capital employedFY 2025 · to 31 Dec 2025-14.5%
Revenue growthFY 2025 · to 31 Dec 202515.2%
Share count trendFY 2025 · to 17 Mar 20260.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$140K

Analyst forecasts

No analyst forecasts yet.